Back to
UBS Group AG
QNTM6 quarters
Position history for
UBS Group AG's holdings in QUANTUM BIOPHARMA LTD
Yes. Ubs holds 33,405 shares of QNTM (Quantum Biopharma), worth $120,926, as of its Q2 2026 13F filing. It increased the position from 7,237 shares in Q1 2026. Ubs has held QNTM since Q1 2025, across 6 quarterly 13F filings.
Current Value
$120,926
Current Shares
33,405
Total Value Change
+$108,482
Total Shares Change
+31,791
Quarter-by-Quarter History
Other major holders of QNTM: Virtu Financial LLC, LPL Financial LLC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC